Literature DB >> 21893975

Epidemiology of interdialytic ambulatory hypertension and the role of volume excess.

Rajiv Agarwal1.   

Abstract

BACKGROUND: The epidemiology of hypertension among hemodialysis (HD) patients is difficult to describe accurately because of difficulties in the assessment of blood pressure (BP).
METHODS: Using 44-hour interdialytic ambulatory BP measurements, we describe the epidemiology of hypertension in a cohort of 369 patients. To seek correlates of hypertension control, antihypertensive agents were withdrawn among patients with controlled hypertension and ambulatory BP monitoring was repeated.
RESULTS: Hypertension (defined as an average ambulatory systolic BP ≥135 mm Hg or diastolic BP ≥85 mm Hg, or the use of antihypertensive medications) was prevalent in 82% of the patients and independently associated with epoetin use, lower body mass index and fewer years on dialysis. Although 89% of the patients were being treated, hypertension was controlled adequately in only 38%. Poor control was independently associated with greater antihypertensive drug use. Inferior vena cava (IVC) diameter in expiration was associated with increased risk of poorly controlled hypertension both in cross-sectional analysis and after withdrawal of antihypertensive drugs.
CONCLUSIONS: Interdialytic hypertension is highly prevalent and difficult to control among HD patients. End-expiration IVC diameter is associated with poor control of hypertension in cross-sectional analyses as well as after washout of antihypertensive drugs. Among HD patients, an attractive target for improving hypertension control appears to be the reduction of extracellular fluid volume.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893975      PMCID: PMC3182044          DOI: 10.1159/000331067

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  30 in total

Review 1.  Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.

Authors:  Rajiv Agarwal; Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

Review 2.  Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure.

Authors:  Rajiv Agarwal; Aldo J Peixoto; Sergio F F Santos; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 8.237

3.  Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

Authors:  Dick de Zeeuw; Rajiv Agarwal; Michael Amdahl; Paul Audhya; Daniel Coyne; Tushar Garimella; Hans-Henrik Parving; Yili Pritchett; Giuseppe Remuzzi; Eberhard Ritz; Dennis Andress
Journal:  Lancet       Date:  2010-11-06       Impact factor: 79.321

4.  Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study.

Authors:  M V Rocco; G Yan; R J Heyka; R Benz; A K Cheung
Journal:  Am J Nephrol       Date:  2001 Jul-Aug       Impact factor: 3.754

5.  Inferior vena cava diameter and left atrial diameter measure volume but not dry weight.

Authors:  Rajiv Agarwal; J Michael Bouldin; Robert P Light; Ashok Garg
Journal:  Clin J Am Soc Nephrol       Date:  2011-02-17       Impact factor: 8.237

6.  Blood pressure and mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

Review 7.  Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA).

Authors:  Reto Krapf; Henry N Hulter
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

8.  Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients.

Authors:  Sangeetha Satyan; Robert P Light; Rajiv Agarwal
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.

Authors:  Natalya Bodyak; Juan Carlos Ayus; Steven Achinger; Venkatesha Shivalingappa; Qingen Ke; Yee-Shiuan Chen; Debra L Rigor; Isaac Stillman; Hector Tamez; Paul E Kroeger; Ruth R Wu-Wong; S Ananth Karumanchi; Ravi Thadhani; Peter M Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

View more
  23 in total

1.  Night-time blood pressure and pulse wave velocity in dialysis patients.

Authors:  Xiurong Li; Qingbo Jiang; Wenhui Wu; Xianlin Xu; Liying Miao; Lina Jin; Lina Xue; Tian Huang; Jia Di; Jinfeng Liu; Xiaozhou He
Journal:  Clin Exp Nephrol       Date:  2017-08-08       Impact factor: 2.801

Review 2.  Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2019-08-28       Impact factor: 3.455

Review 3.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

Review 4.  Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Curr Heart Fail Rep       Date:  2017-10

5.  Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

Review 6.  Pharmacotherapy of Hypertension in Chronic Dialysis Patients.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 7.  The controversies of diagnosing and treating hypertension among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

Review 8.  Antihypertensive Agents in the Dialysis Patient.

Authors:  Michelle A Fravel; Elizabeth Bald; Mony Fraer
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

Review 9.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

10.  Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure.

Authors:  Teena Tandon; Arjun D Sinha; Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-01-24       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.